Fanconi Syndrome clinical trials
The registry lists 15 studies for Fanconi Syndrome across 9 countries. 5 are recruiting or about to start. 4 of them are mainly about Fanconi Syndrome (how this is decided). Per ClinicalTrials.gov, last updated 2026-10-29.
Get an email when these change. Save the Fanconi Syndrome studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Who runs them
Rocket Pharmaceuticals Inc. (4) · The First Affiliated Hospital with Nanjing Medical University (2) · Novartis Pharmaceuticals (2) · Assistance Publique - Hôpitaux de Paris (1) · CENTOGENE GmbH Rostock (1) · Connecticut Children's Medical Center (1) · Cystinosis Research Foundation (1) · Centre Hospitalier Universitaire de Liege (1)
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
The study
- Mar 2027Accuracy of Home Lactate Meter and Accu-chek Glucometer in Patients With Glycogen Storage Disease · Connecticut Children's Medical Center
Who these studies take
Of the 4 Fanconi Syndrome studies recruiting now, 1 (25%) set no upper age limit and 2 (50%) stop at 75 or younger. 2 (50%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 0 (0%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 1 (25%) | 1 (25%) |
| 18 | 3 (75%) | 3 (75%) |
| 30 | 3 (75%) | 3 (75%) |
| 40 | 3 (75%) | 3 (75%) |
| 50 | 3 (75%) | 3 (75%) |
| 65 | 2 (50%) | 2 (50%) |
| 75 | 2 (50%) | 2 (50%) |
| 85 | 1 (25%) | 1 (25%) |
Across all 15 studies, recruiting or not: 40% stop at 75 or younger and 40% at 65; 80% take children; 0% are for women only and 0% for men only; 7% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
Studies
Recruiting first, then most recently updated. Showing 15 of 15. search them.
- Accuracy of Home Lactate Meter and Accu-chek Glucometer in Patients With Glycogen Storage DiseaseRecruitingNCT074595821 country
- DFT383 in Pediatric Participants With Nephropathic CystinosisRecruitingNCT06910813Phase 1/21 country
- A Study Comparing the Necessity of a Second Transurethral Resection in High-Risk Non-Muscle-Invasive Bladder Cancer Patients With Negative Results From Post-Initial Resection Urine Genome-Wide Low-Depth SequencingRecruitingNCT07036731Not applicable1 country
- The Necessity of a Second Transurethral Resection in High-risk Non-muscle-invasive Bladder Cancer Patients With Negative Urine Biomarker After Initial Transurethral ResectionRecruitingNCT06287541Not applicable1 country
- Observational Follow-up Study of Haplo-identical Transplants in Fanconi DiseaseNot yet recruitingNCT05903365
- Long-Term Follow-up of Subjects With Fanconi Anaemia Subtype A Treated With ex Vivo Gene TherapyActive, not recruitingNCT044377711 country
- Gene Therapy for Fanconi Anemia, Complementation Group AActive, not recruitingNCT04248439Phase 21 country
- Baby Detect : Genomic Newborn ScreeningCompletedNCT056874741 country
- Lentiviral-mediated Gene Therapy for Pediatric Patients With Fanconi Anemia Subtype AActive, not recruitingNCT04069533Phase 22 countries
- Biomarker for Cystinosis Disease: BioCystinosis (BioCystinosis)WithdrawnNCT028375233 countries
- A Clinical Trial to Evaluate the Safety of RP-L102 in Pediatric Subjects With Fanconi Anemia Subtype AStatus unknownNCT03814408Phase 11 country
- Study of Deferasirox in Iron Overload From Beta-thalassemia Unable to be Treated With Deferoxamine or Chronic AnemiasCompletedNCT00061763Phase 21 country
- Fanconi Syndrome Due to ARVs in HIV-Infected PersonsCompletedNCT004991872 countries
- Cure Cystinosis International RegistryStatus unknownNCT013278071 country
- Evaluation of Fanconi Syndrome and CystinosisCompletedNCT00004350